- Novavax (NASDAQ:NVAX) announces that R&D chief Gregory Glenn, M.D., will present data on NVX-CoV2373, its COVID-19 vaccine candidate, at the World Vaccine Congress Europe this week.
- The presentation is scheduled for 8:10 am ET but the specific day is not provided.
- NVX-CoV2373 is currently being tested in a Phase 3 trial in the U.K. and two Phase 2 studies (South Africa and the U.S./Australia) that launched in August.
- https://seekingalpha.com/news/3623651-novavax-to-present-covidminus-19-vaccine-data-this-week
Tuesday, October 20, 2020
Novavax to present COVID-19 vaccine data this week
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.